NCT00130182View on ClinicalTrials.gov

A Study in Pediatric Patients With Cystic Fibrosis Lung Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

September 30, 2006

Conditions
Cystic Fibrosis
Interventions
DRUG

denufosol tetrasodium (INS37217)

Trial Locations (3)

55455

General Clinic Research Center University of Minnesota, Minneapolis

The Minnesota CF Center, Minneapolis

80218

The Children's Hospital, Denver

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00130182 - A Study in Pediatric Patients With Cystic Fibrosis Lung Disease | Biotech Hunter | Biotech Hunter